---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-015514"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2022-08-08T23:59:59+00:00"
generated_at: "2026-06-24T02:35:23.319991+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# RxSight Q2 revenue $11.4M (+132% YoY); raises FY22 guidance to $44-46M

## Summary
- Revenue $11.4M (+132% YoY); sold 49 LDDs, installed base 294 (+126% YoY).
- LAL procedure volumes 5,400 (+196% YoY).
- Net loss $(16.7)M ($0.61/share); adjusted loss $(13.8)M ($0.50/share).
- Raised FY22 revenue guidance to $44-46M (95-104% growth); gross margin guidance to 37-38%.
- Cash and investments $128.6M; long-term debt $39.9M.

## SEC filing metadata
- accession: 0000950170-22-015514
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2022-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/0000950170-22-015514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/rxst-20220808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-015514
- JSON: https://secwatch.observer/filing/0000950170-22-015514.json
- Plain text: https://secwatch.observer/filing/0000950170-22-015514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.